These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11967649)

  • 1. Bradykinesia in Huntington's disease. A prospective, follow-up study.
    García Ruiz PJ; Hernández J; Cantarero S; Bartolomé M; Sánchez Bernardos V; García de Yébenez J
    J Neurol; 2002 Apr; 249(4):437-40. PubMed ID: 11967649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinesia in Huntington's disease.
    Garcia Ruiz PJ; Gomez Tortosa E; Sanchez Bernados V; Rojo A; Fontán A; Garcia de Yebenes J
    Clin Neuropharmacol; 2000; 23(1):50-2. PubMed ID: 10682231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capit timed tests quantify age-related motor decline in normal subjects.
    Ruiz PJ; Bernardos VS; Bartolomé M; Torres AG
    J Neurol Sci; 2007 Sep; 260(1-2):283-5. PubMed ID: 17524426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ActiTrac (ambulatory activity monitor) in Parkinson's Disease.
    Garcia Ruiz PJ; Sanchez Bernardos V
    J Neurol Sci; 2008 Jul; 270(1-2):67-9. PubMed ID: 18325537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex movement behaviour and progression of Huntington's disease.
    Andrich J; Saft C; Ostholt N; Müller T
    Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unified Huntington's disease rating scale: a follow up.
    Siesling S; van Vugt JP; Zwinderman KA; Kieburtz K; Roos RA
    Mov Disord; 1998 Nov; 13(6):915-9. PubMed ID: 9827615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
    Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
    Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology.
    Fenney A; Jog MS; Duval C
    Brain Res; 2008 Feb; 1193():67-75. PubMed ID: 18177845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.
    van Vugt JP; Piet KK; Vink LJ; Siesling S; Zwinderman AH; Middelkoop HA; Roos RA
    Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The usefulness of timed motor tests in assessing Parkinson's disease].
    García-Ruiz PJ; Sánchez-Bernardos V; Cabo-López I
    Rev Neurol; 2009 Jun 16-30; 48(12):617-9. PubMed ID: 19507119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unified Huntington's disease rating scale: clinical practice and a critical approach.
    Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
    Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological deterioration over time in patients with Huntington's disease.
    Lefaucheur JP; Ménard-Lefaucheur I; Maison P; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
    Mov Disord; 2006 Sep; 21(9):1350-4. PubMed ID: 16721731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of the contingent negative variation in Huntington's disease: correlations with clinical features.
    de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
    J Neurol Sci; 2007 Mar; 254(1-2):84-9. PubMed ID: 17300807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.
    Mov Disord; 1996 Mar; 11(2):136-42. PubMed ID: 8684382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural deficits in Huntington's disease when performing motor skills involved in daily living.
    Panzera R; Salomonczyk D; Pirogovosky E; Simmons R; Goldstein J; Corey-Bloom J; Gilbert PE
    Gait Posture; 2011 Mar; 33(3):457-61. PubMed ID: 21256027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an attentional strategy on movement-related potentials recorded from subjects with Huntington's disease.
    Johnson KA; Cunnington R; Bradshaw JL; Chiu E; Iansek R
    Mov Disord; 2002 Sep; 17(5):998-1003. PubMed ID: 12360549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypokinesia in Huntington's disease.
    van Vugt JP; van Hilten BJ; Roos RA
    Mov Disord; 1996 Jul; 11(4):384-8. PubMed ID: 8813217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning.
    Reedeker N; Van Der Mast RC; Giltay EJ; Van Duijn E; Roos RA
    Mov Disord; 2010 Aug; 25(11):1612-8. PubMed ID: 20629165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease.
    Lefaucheur JP; Bachoud-Levi AC; Bourdet C; Grandmougin T; Hantraye P; Cesaro P; Degos JD; Peschanski M; Lisovoski F
    Mov Disord; 2002 Nov; 17(6):1294-301. PubMed ID: 12465071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two years' follow-up of rivastigmine treatment in Huntington disease.
    de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
    Clin Neuropharmacol; 2007; 30(1):43-6. PubMed ID: 17272969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.